Ignite Creation Date:
2025-12-26 @ 10:36 AM
Ignite Modification Date:
2025-12-31 @ 2:14 PM
Study NCT ID:
NCT06582628
Status:
RECRUITING
Last Update Posted:
2024-12-02
First Post:
2024-08-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Talazoparib Plus Enzalutamide After Progression to Abiraterone in Metastatic Prostate Cancer: (TEAM PC)
Sponsor:
Fundacion Oncosur
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-07-05
Start Date Type:
ACTUAL
Primary Completion Date:
2026-01-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-10-31
Completion Date Type:
ESTIMATED
First Submit Date:
2024-08-30
First Submit QC Date:
None
Study First Post Date:
2024-09-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-29
Last Update Post Date:
2024-12-02
Last Update Post Date Type:
ACTUAL